Benlysta, generically known as belimumab, is a prescription medication specifically designed for the treatment of systemic lupus erythematosus (SLE), a chronic autoimmune disease where the immune system attacks its own tissues, causing widespread inflammation and tissue damage in the affected organs. It belongs to a class of drugs known as monoclonal antibodies, which target and neutralize specific proteins in the body. Benlysta works by inhibiting the activity of B-lymphocyte stimulator (BLyS) protein, which plays a key role in the survival and proliferation of B cells, a type of white blood cell involved in the autoimmune response. By blocking BLyS, Benlysta reduces the number of abnormal B cells, thereby helping to decrease inflammation and control the symptoms of lupus. It is administered via intravenous infusion or as a subcutaneous injection and is intended for use in patients who have not responded adequately to other lupus treatments.
When using BENLYSTA, it's crucial to take certain precautions to ensure your safety and the effectiveness of the medication. One important consideration is whether BENLYSTA may affect your ability to drive or operate heavy machinery; this medication can cause dizziness or fatigue in some individuals, so it's essential to know how it affects you before engaging in such activities. Common side effects include nausea, diarrhea, fever, and infections, while rare but serious side effects can include severe allergic reactions and increased risk of certain cancers. Always follow your doctor's instructions closely and read the label that comes with the medicine to understand the proper usage and potential side effects. It's also vital to inform your doctor about all other medications you're taking, as BENLYSTA can interact with other drugs, potentially leading to adverse effects. Adhering to these guidelines will help ensure your treatment is both safe and effective.